ML19267A301

From kanterella
Jump to navigation Jump to search
September 20, 2019 Letter from Exubrion Therapeutics Notice of Intent to Submit a Hypothetical License Amendment for Treatment of Dogs with Synovetin Oa Containing Sn-117m and Request for pre-submittal Meeting
ML19267A301
Person / Time
Issue date: 09/20/2019
From: Selover P
Exubrion Therapeutics
To: Christian Einberg
NRC/NMSS/DMSST
IRENE WU MSST
References
Download: ML19267A301 (2)